Aldesleukin Completed Phase 1 Trials for Unspecified Adult Solid Tumor, Protocol Specific Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00005604Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors
NCT00019357Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy